Quantcast

Latest Vaccination Stories

2014-05-27 04:21:46

BLUE BELL, Pa., May 27, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced that its 90%-owned subsidiary, VGX Animal Health, Inc. (VAH), has concluded an agreement for the sale of its animal health assets to Plumbline Life Sciences, Inc. (PLS) of Korea. The assets being transferred include an exclusive license with Inovio for animal applications of its growth hormone-releasing hormone (GHRH) technology and animal DNA vaccines plus a non-exclusive license...

Parasite-Blocking Antigen Discovery May Lead To Malaria Vaccine
2014-05-23 08:37:58

[ Watch the Video: Protein May Lead To Malaria Vaccine ] Lawrence LeBlond for redOrbit.com - Your Universe Online Malaria remains a dangerous disease in the developing world, killing more than 627,000 people a year, according to the World Health Organization (WHO). Because most deaths associated with malaria occur in children in Sub-Saharan Africa, finding a vaccine against the deadly virus is all too important. New research, by a team from Rhode Island Hospital (RIH), has uncovered...

2014-05-23 04:20:51

BLUE BELL, Pa., May 23, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced that at the Company's Annual General Meeting held May 22, 2014, the Company's shareholders approved the proposal of a reverse split of the Company's common stock. The Company's Board of Directors subsequently approved the immediate implementation of a 1-for-4 reverse stock split of Inovio's common stock, where each 4 shares of issued and outstanding common stock and equivalents...

2014-05-21 08:28:31

DALLAS, May 21, 2014 /PRNewswire/ -- ReportsnReports.com offers "Vaccines: The End of Illness" and other vaccine market research reports focusing on vaccine technology, HIV, China's animal vaccine industry and cancer vaccine partnering terms and agreements. Vaccines: The End of Illness 2014 market research report focuses on the most recent vaccine research [http://www.reportsnreports.com/reports/286914-vaccines-the-end-of-illness.html ], emphasizing their reputation as...

2014-05-21 08:25:01

WSPA campaign protects dogs and safeguards communities from rabies TORONTO, May 21, 2014 /CNW/ - Thousands of people and millions of dogs die every year because of rabies, a 100% preventable disease. Fear of rabies causes the mass killing of dogs all over the world but an international project from the World Society for the Protection of Animals (WSPA), stops the killing and instead sets up dog vaccination clinics - protecting dogs from being killed and everyone from rabies....

2014-05-20 08:34:45

WORCESTER, Mass. and TORONTO, May 20, 2014 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced two upcoming presentations demonstrating that certain patients with early stage breast cancer who receive AE37 may benefit in terms of reduced risk of relapse. The AE37 breast cancer vaccine is being developed by the Company's wholly-owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com). The presentations will be made at the 50(th)...

2014-05-19 23:07:53

Dr. William Hearl will discuss the missing link in enhancing the effectiveness of DNA vaccines in a panel discussion on Wednesday, May 21 hosted by Ed Butler of the BBC Hershey, PA & Rockville, MD (PRWEB) May 19, 2014 Immunomic Therapeutics, Inc. (ITI), a vaccine pioneer in the biotechnology industry, is proud to announce that the company’s CEO, Dr. William G. Hearl, will be a featured panelist at the prestigious Future in Review (FiRe) Conference hosted by Strategic News Service...

2014-05-16 12:27:03

Anti-Mers-CoV Synthetic Replikins Vaccine(TM) Available Now to Vaccinate Camels LONDON, May 16, 2014 /PRNewswire/ -- A Replikins analysis by Bioradar, Ltd of Mers-CoV in all isolates of the virus genes reported to date in Pubmed from both humans and camels has revealed specific shared gene Replikin structures that are not just homologous but are identical in the virus genes infecting both camels and humans, and conserved since 2012 in cases from all countries affected. Replikins, Ltd. has...

2014-05-15 12:36:33

LONDON, May 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global H1N1 Vaccines Industryhttp://www.reportbuyer.com/pharma_healthcare/therapeutic/global_h1n1_vaccines_industry.html This report analyzes the Global market for H1N1 Vaccines in US$ Million. The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2018. The...

2014-05-15 12:33:41

Public health initiative aims to increase unacceptably low adult vaccination rates PHILADELPHIA, May 15, 2014 /PRNewswire-USNewswire/ -- The American College of Physicians (ACP), CECity, and Pfizer Inc. (NYSE:PFE) have announced a new initiative designed to increase adult immunization rates by assisting physicians and other health care providers in strongly recommending appropriate vaccination and tracking adult immunization rates for quality measurement and improvement. The three...


Latest Vaccination Reference Libraries

0_ac8af9115d7f37daaaa2af4dba273fb1
2011-01-11 14:17:29

The Cowpox virus causes a skin disease known as cowpox. It is related to the vaccinia virus and gained its name because it spread by dairymaids touching the udders of infected cows. It manifests as red blisters. It is similar to smallpox although much milder and was actually the basis of the first smallpox vaccine. A person who recovers from cowpox is immune to smallpox. In 1980 the World Health Organization announced that smallpox was the first disease to be eradicated world wide by a...

More Articles (1 articles) »
Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.